Measure Twice, Cut Once: Therapeutic Editing of HSPCs Requires Precise Planning
- PMID: 30951659
- DOI: 10.1016/j.stem.2019.03.001
Measure Twice, Cut Once: Therapeutic Editing of HSPCs Requires Precise Planning
Abstract
Hematologic diseases may be among the first clinical targets for therapeutic gene editing. In this issue of Cell Stem Cell, Schiroli et al. (2019) report a thorough, unbiased investigation of the impact of gene editing on hematopoietic stem and progenitor function and offer a clear path forward for editing in multiple tissues and conditions.
Copyright © 2019 Elsevier Inc. All rights reserved.
Comment on
-
Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response.Cell Stem Cell. 2019 Apr 4;24(4):551-565.e8. doi: 10.1016/j.stem.2019.02.019. Epub 2019 Mar 21. Cell Stem Cell. 2019. PMID: 30905619 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources